Global Viral Vector-Based Gene Therapy Market Research Report 2026(Status and Outlook)
The global Viral Vector-Based Gene Therapy market size was estimated at USD nan million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of nan% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Viral Vector-Based Gene Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Viral Vector-Based Gene Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Viral Vector-Based Gene Therapy market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viral Vector-Based Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Viral Vector-Based Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
This report offers a comprehensive and in-depth analysis of the global Viral Vector-Based Gene Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Viral Vector-Based Gene Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Viral Vector-Based Gene Therapy market.
Global Viral Vector-Based Gene Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Sibiono
- Rigvir Group
- Shanghai Pharma (Sunway)
- Amgen
- Spark Therapeutics
- Novartis Gene Therapies
- Daiichi Sankyo
- PTC Therapeutics
Market Segmentation (by Type)
- Adenovirus (AdV)
- Adeno-associated Virus (AAV)
Market Segmentation (by Application)
- Hospital
- Clinic
- Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Viral Vector-Based Gene Therapy Market
Overview of the regional outlook of the Viral Vector-Based Gene Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viral Vector-Based Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Viral Vector-Based Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Viral Vector-Based Gene Therapy
1.2 Key Market Segments
1.2.1 Viral Vector-Based Gene Therapy Segment by Type
1.2.2 Viral Vector-Based Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VIRAL VECTOR-BASED GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Viral Vector-Based Gene Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Viral Vector-Based Gene Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VIRAL VECTOR-BASED GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Viral Vector-Based Gene Therapy Product Life Cycle
3.3 Global Viral Vector-Based Gene Therapy Sales by Manufacturers (2020-2025)
3.4 Global Viral Vector-Based Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Viral Vector-Based Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Viral Vector-Based Gene Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Viral Vector-Based Gene Therapy Market Competitive Situation and Trends
3.8.1 Viral Vector-Based Gene Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Viral Vector-Based Gene Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 VIRAL VECTOR-BASED GENE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Viral Vector-Based Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VIRAL VECTOR-BASED GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Viral Vector-Based Gene Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Viral Vector-Based Gene Therapy Market
5.7 ESG Ratings of Leading Companies
6 VIRAL VECTOR-BASED GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Viral Vector-Based Gene Therapy Sales Market Share by Type (2020-2025)
6.3 Global Viral Vector-Based Gene Therapy Market Size by Type (2020-2025)
6.4 Global Viral Vector-Based Gene Therapy Price by Type (2020-2025)
7 VIRAL VECTOR-BASED GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Viral Vector-Based Gene Therapy Market Sales by Application (2020-2025)
7.3 Global Viral Vector-Based Gene Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Viral Vector-Based Gene Therapy Sales Growth Rate by Application (2020-2025)
8 VIRAL VECTOR-BASED GENE THERAPY MARKET SALES BY REGION
8.1 Global Viral Vector-Based Gene Therapy Sales by Region
8.1.1 Global Viral Vector-Based Gene Therapy Sales by Region
8.1.2 Global Viral Vector-Based Gene Therapy Sales Market Share by Region
8.2 Global Viral Vector-Based Gene Therapy Market Size by Region
8.2.1 Global Viral Vector-Based Gene Therapy Market Size by Region
8.2.2 Global Viral Vector-Based Gene Therapy Market Size by Region
8.3 North America
8.3.1 North America Viral Vector-Based Gene Therapy Sales by Country
8.3.2 North America Viral Vector-Based Gene Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Viral Vector-Based Gene Therapy Sales by Country
8.4.2 Europe Viral Vector-Based Gene Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Viral Vector-Based Gene Therapy Sales by Region
8.5.2 Asia Pacific Viral Vector-Based Gene Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Viral Vector-Based Gene Therapy Sales by Country
8.6.2 South America Viral Vector-Based Gene Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Viral Vector-Based Gene Therapy Sales by Region
8.7.2 Middle East and Africa Viral Vector-Based Gene Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 VIRAL VECTOR-BASED GENE THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Viral Vector-Based Gene Therapy by Region(2020-2025)
9.2 Global Viral Vector-Based Gene Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Viral Vector-Based Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Viral Vector-Based Gene Therapy Production
9.4.1 North America Viral Vector-Based Gene Therapy Production Growth Rate (2020-2025)
9.4.2 North America Viral Vector-Based Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Viral Vector-Based Gene Therapy Production
9.5.1 Europe Viral Vector-Based Gene Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Viral Vector-Based Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Viral Vector-Based Gene Therapy Production (2020-2025)
9.6.1 Japan Viral Vector-Based Gene Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Viral Vector-Based Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Viral Vector-Based Gene Therapy Production (2020-2025)
9.7.1 China Viral Vector-Based Gene Therapy Production Growth Rate (2020-2025)
9.7.2 China Viral Vector-Based Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sibiono
10.1.1 Sibiono Basic Information
10.1.2 Sibiono Viral Vector-Based Gene Therapy Product Overview
10.1.3 Sibiono Viral Vector-Based Gene Therapy Product Market Performance
10.1.4 Sibiono Business Overview
10.1.5 Sibiono SWOT Analysis
10.1.6 Sibiono Recent Developments
10.2 Rigvir Group
10.2.1 Rigvir Group Basic Information
10.2.2 Rigvir Group Viral Vector-Based Gene Therapy Product Overview
10.2.3 Rigvir Group Viral Vector-Based Gene Therapy Product Market Performance
10.2.4 Rigvir Group Business Overview
10.2.5 Rigvir Group SWOT Analysis
10.2.6 Rigvir Group Recent Developments
10.3 Shanghai Pharma (Sunway)
10.3.1 Shanghai Pharma (Sunway) Basic Information
10.3.2 Shanghai Pharma (Sunway) Viral Vector-Based Gene Therapy Product Overview
10.3.3 Shanghai Pharma (Sunway) Viral Vector-Based Gene Therapy Product Market Performance
10.3.4 Shanghai Pharma (Sunway) Business Overview
10.3.5 Shanghai Pharma (Sunway) SWOT Analysis
10.3.6 Shanghai Pharma (Sunway) Recent Developments
10.4 Amgen
10.4.1 Amgen Basic Information
10.4.2 Amgen Viral Vector-Based Gene Therapy Product Overview
10.4.3 Amgen Viral Vector-Based Gene Therapy Product Market Performance
10.4.4 Amgen Business Overview
10.4.5 Amgen Recent Developments
10.5 Spark Therapeutics
10.5.1 Spark Therapeutics Basic Information
10.5.2 Spark Therapeutics Viral Vector-Based Gene Therapy Product Overview
10.5.3 Spark Therapeutics Viral Vector-Based Gene Therapy Product Market Performance
10.5.4 Spark Therapeutics Business Overview
10.5.5 Spark Therapeutics Recent Developments
10.6 Novartis Gene Therapies
10.6.1 Novartis Gene Therapies Basic Information
10.6.2 Novartis Gene Therapies Viral Vector-Based Gene Therapy Product Overview
10.6.3 Novartis Gene Therapies Viral Vector-Based Gene Therapy Product Market Performance
10.6.4 Novartis Gene Therapies Business Overview
10.6.5 Novartis Gene Therapies Recent Developments
10.7 Daiichi Sankyo
10.7.1 Daiichi Sankyo Basic Information
10.7.2 Daiichi Sankyo Viral Vector-Based Gene Therapy Product Overview
10.7.3 Daiichi Sankyo Viral Vector-Based Gene Therapy Product Market Performance
10.7.4 Daiichi Sankyo Business Overview
10.7.5 Daiichi Sankyo Recent Developments
10.8 PTC Therapeutics
10.8.1 PTC Therapeutics Basic Information
10.8.2 PTC Therapeutics Viral Vector-Based Gene Therapy Product Overview
10.8.3 PTC Therapeutics Viral Vector-Based Gene Therapy Product Market Performance
10.8.4 PTC Therapeutics Business Overview
10.8.5 PTC Therapeutics Recent Developments
11 VIRAL VECTOR-BASED GENE THERAPY MARKET FORECAST BY REGION
11.1 Global Viral Vector-Based Gene Therapy Market Size Forecast
11.2 Global Viral Vector-Based Gene Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Viral Vector-Based Gene Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Viral Vector-Based Gene Therapy Market Size Forecast by Region
11.2.4 South America Viral Vector-Based Gene Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Viral Vector-Based Gene Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Viral Vector-Based Gene Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Viral Vector-Based Gene Therapy by Type (2026-2035)
12.1.2 Global Viral Vector-Based Gene Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Viral Vector-Based Gene Therapy by Type (2026-2035)
12.2 Global Viral Vector-Based Gene Therapy Market Forecast by Application (2026-2035)
12.2.1 Global Viral Vector-Based Gene Therapy Sales (K MT) Forecast by Application
12.2.2 Global Viral Vector-Based Gene Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Viral Vector-Based Gene Therapy
1.2 Key Market Segments
1.2.1 Viral Vector-Based Gene Therapy Segment by Type
1.2.2 Viral Vector-Based Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VIRAL VECTOR-BASED GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Viral Vector-Based Gene Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Viral Vector-Based Gene Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VIRAL VECTOR-BASED GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Viral Vector-Based Gene Therapy Product Life Cycle
3.3 Global Viral Vector-Based Gene Therapy Sales by Manufacturers (2020-2025)
3.4 Global Viral Vector-Based Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Viral Vector-Based Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Viral Vector-Based Gene Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Viral Vector-Based Gene Therapy Market Competitive Situation and Trends
3.8.1 Viral Vector-Based Gene Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Viral Vector-Based Gene Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 VIRAL VECTOR-BASED GENE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Viral Vector-Based Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VIRAL VECTOR-BASED GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Viral Vector-Based Gene Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Viral Vector-Based Gene Therapy Market
5.7 ESG Ratings of Leading Companies
6 VIRAL VECTOR-BASED GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Viral Vector-Based Gene Therapy Sales Market Share by Type (2020-2025)
6.3 Global Viral Vector-Based Gene Therapy Market Size by Type (2020-2025)
6.4 Global Viral Vector-Based Gene Therapy Price by Type (2020-2025)
7 VIRAL VECTOR-BASED GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Viral Vector-Based Gene Therapy Market Sales by Application (2020-2025)
7.3 Global Viral Vector-Based Gene Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Viral Vector-Based Gene Therapy Sales Growth Rate by Application (2020-2025)
8 VIRAL VECTOR-BASED GENE THERAPY MARKET SALES BY REGION
8.1 Global Viral Vector-Based Gene Therapy Sales by Region
8.1.1 Global Viral Vector-Based Gene Therapy Sales by Region
8.1.2 Global Viral Vector-Based Gene Therapy Sales Market Share by Region
8.2 Global Viral Vector-Based Gene Therapy Market Size by Region
8.2.1 Global Viral Vector-Based Gene Therapy Market Size by Region
8.2.2 Global Viral Vector-Based Gene Therapy Market Size by Region
8.3 North America
8.3.1 North America Viral Vector-Based Gene Therapy Sales by Country
8.3.2 North America Viral Vector-Based Gene Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Viral Vector-Based Gene Therapy Sales by Country
8.4.2 Europe Viral Vector-Based Gene Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Viral Vector-Based Gene Therapy Sales by Region
8.5.2 Asia Pacific Viral Vector-Based Gene Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Viral Vector-Based Gene Therapy Sales by Country
8.6.2 South America Viral Vector-Based Gene Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Viral Vector-Based Gene Therapy Sales by Region
8.7.2 Middle East and Africa Viral Vector-Based Gene Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 VIRAL VECTOR-BASED GENE THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Viral Vector-Based Gene Therapy by Region(2020-2025)
9.2 Global Viral Vector-Based Gene Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Viral Vector-Based Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Viral Vector-Based Gene Therapy Production
9.4.1 North America Viral Vector-Based Gene Therapy Production Growth Rate (2020-2025)
9.4.2 North America Viral Vector-Based Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Viral Vector-Based Gene Therapy Production
9.5.1 Europe Viral Vector-Based Gene Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Viral Vector-Based Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Viral Vector-Based Gene Therapy Production (2020-2025)
9.6.1 Japan Viral Vector-Based Gene Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Viral Vector-Based Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Viral Vector-Based Gene Therapy Production (2020-2025)
9.7.1 China Viral Vector-Based Gene Therapy Production Growth Rate (2020-2025)
9.7.2 China Viral Vector-Based Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sibiono
10.1.1 Sibiono Basic Information
10.1.2 Sibiono Viral Vector-Based Gene Therapy Product Overview
10.1.3 Sibiono Viral Vector-Based Gene Therapy Product Market Performance
10.1.4 Sibiono Business Overview
10.1.5 Sibiono SWOT Analysis
10.1.6 Sibiono Recent Developments
10.2 Rigvir Group
10.2.1 Rigvir Group Basic Information
10.2.2 Rigvir Group Viral Vector-Based Gene Therapy Product Overview
10.2.3 Rigvir Group Viral Vector-Based Gene Therapy Product Market Performance
10.2.4 Rigvir Group Business Overview
10.2.5 Rigvir Group SWOT Analysis
10.2.6 Rigvir Group Recent Developments
10.3 Shanghai Pharma (Sunway)
10.3.1 Shanghai Pharma (Sunway) Basic Information
10.3.2 Shanghai Pharma (Sunway) Viral Vector-Based Gene Therapy Product Overview
10.3.3 Shanghai Pharma (Sunway) Viral Vector-Based Gene Therapy Product Market Performance
10.3.4 Shanghai Pharma (Sunway) Business Overview
10.3.5 Shanghai Pharma (Sunway) SWOT Analysis
10.3.6 Shanghai Pharma (Sunway) Recent Developments
10.4 Amgen
10.4.1 Amgen Basic Information
10.4.2 Amgen Viral Vector-Based Gene Therapy Product Overview
10.4.3 Amgen Viral Vector-Based Gene Therapy Product Market Performance
10.4.4 Amgen Business Overview
10.4.5 Amgen Recent Developments
10.5 Spark Therapeutics
10.5.1 Spark Therapeutics Basic Information
10.5.2 Spark Therapeutics Viral Vector-Based Gene Therapy Product Overview
10.5.3 Spark Therapeutics Viral Vector-Based Gene Therapy Product Market Performance
10.5.4 Spark Therapeutics Business Overview
10.5.5 Spark Therapeutics Recent Developments
10.6 Novartis Gene Therapies
10.6.1 Novartis Gene Therapies Basic Information
10.6.2 Novartis Gene Therapies Viral Vector-Based Gene Therapy Product Overview
10.6.3 Novartis Gene Therapies Viral Vector-Based Gene Therapy Product Market Performance
10.6.4 Novartis Gene Therapies Business Overview
10.6.5 Novartis Gene Therapies Recent Developments
10.7 Daiichi Sankyo
10.7.1 Daiichi Sankyo Basic Information
10.7.2 Daiichi Sankyo Viral Vector-Based Gene Therapy Product Overview
10.7.3 Daiichi Sankyo Viral Vector-Based Gene Therapy Product Market Performance
10.7.4 Daiichi Sankyo Business Overview
10.7.5 Daiichi Sankyo Recent Developments
10.8 PTC Therapeutics
10.8.1 PTC Therapeutics Basic Information
10.8.2 PTC Therapeutics Viral Vector-Based Gene Therapy Product Overview
10.8.3 PTC Therapeutics Viral Vector-Based Gene Therapy Product Market Performance
10.8.4 PTC Therapeutics Business Overview
10.8.5 PTC Therapeutics Recent Developments
11 VIRAL VECTOR-BASED GENE THERAPY MARKET FORECAST BY REGION
11.1 Global Viral Vector-Based Gene Therapy Market Size Forecast
11.2 Global Viral Vector-Based Gene Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Viral Vector-Based Gene Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Viral Vector-Based Gene Therapy Market Size Forecast by Region
11.2.4 South America Viral Vector-Based Gene Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Viral Vector-Based Gene Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Viral Vector-Based Gene Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Viral Vector-Based Gene Therapy by Type (2026-2035)
12.1.2 Global Viral Vector-Based Gene Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Viral Vector-Based Gene Therapy by Type (2026-2035)
12.2 Global Viral Vector-Based Gene Therapy Market Forecast by Application (2026-2035)
12.2.1 Global Viral Vector-Based Gene Therapy Sales (K MT) Forecast by Application
12.2.2 Global Viral Vector-Based Gene Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Viral Vector-Based Gene Therapy Market Size by Type (M USD)
Table 4. Global Viral Vector-Based Gene Therapy Market Size by Application
Table 5. Viral Vector-Based Gene Therapy Market Size Comparison by Region (M USD)
Table 6. Global Viral Vector-Based Gene Therapy Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Viral Vector-Based Gene Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Viral Vector-Based Gene Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Viral Vector-Based Gene Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector-Based Gene Therapy as of 2025)
Table 11. Global Market Viral Vector-Based Gene Therapy Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Viral Vector-Based Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Viral Vector-Based Gene Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Viral Vector-Based Gene Therapy Sales by Type (K MT)
Table 27. Global Viral Vector-Based Gene Therapy Market Size by Type (M USD)
Table 28. Global Viral Vector-Based Gene Therapy Sales (K MT) by Type (2020-2025)
Table 29. Global Viral Vector-Based Gene Therapy Sales Market Share by Type (2020-2025)
Table 30. Global Viral Vector-Based Gene Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global Viral Vector-Based Gene Therapy Market Share by Type (2020-2025)
Table 32. Global Viral Vector-Based Gene Therapy Price (USD/KG) by Type (2020-2025)
Table 33. Global Viral Vector-Based Gene Therapy Sales (K MT) by Application
Table 34. Global Viral Vector-Based Gene Therapy Market Size by Application
Table 35. Global Viral Vector-Based Gene Therapy Sales by Application (2020-2025) & (K MT)
Table 36. Global Viral Vector-Based Gene Therapy Sales Market Share by Application (2020-2025)
Table 37. Global Viral Vector-Based Gene Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Viral Vector-Based Gene Therapy Market Share by Application (2020-2025)
Table 39. Global Viral Vector-Based Gene Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global Viral Vector-Based Gene Therapy Sales by Region (2020-2025) & (K MT)
Table 41. Global Viral Vector-Based Gene Therapy Sales Market Share by Region (2020-2025)
Table 42. Global Viral Vector-Based Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Viral Vector-Based Gene Therapy Market Size by Region (2020-2025)
Table 44. North America Viral Vector-Based Gene Therapy Sales by Country (2020-2025) & (K MT)
Table 45. North America Viral Vector-Based Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Viral Vector-Based Gene Therapy Sales by Country (2020-2025) & (K MT)
Table 47. Europe Viral Vector-Based Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Viral Vector-Based Gene Therapy Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Viral Vector-Based Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Viral Vector-Based Gene Therapy Sales by Country (2020-2025) & (K MT)
Table 51. South America Viral Vector-Based Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Viral Vector-Based Gene Therapy Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Viral Vector-Based Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Viral Vector-Based Gene Therapy Production (K MT) by Region(2020-2025)
Table 55. Global Viral Vector-Based Gene Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Viral Vector-Based Gene Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global Viral Vector-Based Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Viral Vector-Based Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Viral Vector-Based Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Viral Vector-Based Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Viral Vector-Based Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sibiono Basic Information
Table 63. Sibiono Viral Vector-Based Gene Therapy Product Overview
Table 64. Sibiono Viral Vector-Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sibiono Business Overview
Table 66. Sibiono SWOT Analysis
Table 67. Sibiono Recent Developments
Table 68. Rigvir Group Basic Information
Table 69. Rigvir Group Viral Vector-Based Gene Therapy Product Overview
Table 70. Rigvir Group Viral Vector-Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Rigvir Group Business Overview
Table 72. Rigvir Group SWOT Analysis
Table 73. Rigvir Group Recent Developments
Table 74. Shanghai Pharma (Sunway) Basic Information
Table 75. Shanghai Pharma (Sunway) Viral Vector-Based Gene Therapy Product Overview
Table 76. Shanghai Pharma (Sunway) Viral Vector-Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Shanghai Pharma (Sunway) Business Overview
Table 78. Shanghai Pharma (Sunway) SWOT Analysis
Table 79. Shanghai Pharma (Sunway) Recent Developments
Table 80. Amgen Basic Information
Table 81. Amgen Viral Vector-Based Gene Therapy Product Overview
Table 82. Amgen Viral Vector-Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Amgen Business Overview
Table 84. Amgen Recent Developments
Table 85. Spark Therapeutics Basic Information
Table 86. Spark Therapeutics Viral Vector-Based Gene Therapy Product Overview
Table 87. Spark Therapeutics Viral Vector-Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Spark Therapeutics Business Overview
Table 89. Spark Therapeutics Recent Developments
Table 90. Novartis Gene Therapies Basic Information
Table 91. Novartis Gene Therapies Viral Vector-Based Gene Therapy Product Overview
Table 92. Novartis Gene Therapies Viral Vector-Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Novartis Gene Therapies Business Overview
Table 94. Novartis Gene Therapies Recent Developments
Table 95. Daiichi Sankyo Basic Information
Table 96. Daiichi Sankyo Viral Vector-Based Gene Therapy Product Overview
Table 97. Daiichi Sankyo Viral Vector-Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Daiichi Sankyo Business Overview
Table 99. Daiichi Sankyo Recent Developments
Table 100. PTC Therapeutics Basic Information
Table 101. PTC Therapeutics Viral Vector-Based Gene Therapy Product Overview
Table 102. PTC Therapeutics Viral Vector-Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. PTC Therapeutics Business Overview
Table 104. PTC Therapeutics Recent Developments
Table 105. Global Viral Vector-Based Gene Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global Viral Vector-Based Gene Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America Viral Vector-Based Gene Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America Viral Vector-Based Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe Viral Vector-Based Gene Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe Viral Vector-Based Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific Viral Vector-Based Gene Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific Viral Vector-Based Gene Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Viral Vector-Based Gene Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America Viral Vector-Based Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa Viral Vector-Based Gene Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa Viral Vector-Based Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global Viral Vector-Based Gene Therapy Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global Viral Vector-Based Gene Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global Viral Vector-Based Gene Therapy Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global Viral Vector-Based Gene Therapy Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global Viral Vector-Based Gene Therapy Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Viral Vector-Based Gene Therapy Market Size by Type (M USD)
Table 4. Global Viral Vector-Based Gene Therapy Market Size by Application
Table 5. Viral Vector-Based Gene Therapy Market Size Comparison by Region (M USD)
Table 6. Global Viral Vector-Based Gene Therapy Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Viral Vector-Based Gene Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Viral Vector-Based Gene Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Viral Vector-Based Gene Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector-Based Gene Therapy as of 2025)
Table 11. Global Market Viral Vector-Based Gene Therapy Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Viral Vector-Based Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Viral Vector-Based Gene Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Viral Vector-Based Gene Therapy Sales by Type (K MT)
Table 27. Global Viral Vector-Based Gene Therapy Market Size by Type (M USD)
Table 28. Global Viral Vector-Based Gene Therapy Sales (K MT) by Type (2020-2025)
Table 29. Global Viral Vector-Based Gene Therapy Sales Market Share by Type (2020-2025)
Table 30. Global Viral Vector-Based Gene Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global Viral Vector-Based Gene Therapy Market Share by Type (2020-2025)
Table 32. Global Viral Vector-Based Gene Therapy Price (USD/KG) by Type (2020-2025)
Table 33. Global Viral Vector-Based Gene Therapy Sales (K MT) by Application
Table 34. Global Viral Vector-Based Gene Therapy Market Size by Application
Table 35. Global Viral Vector-Based Gene Therapy Sales by Application (2020-2025) & (K MT)
Table 36. Global Viral Vector-Based Gene Therapy Sales Market Share by Application (2020-2025)
Table 37. Global Viral Vector-Based Gene Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Viral Vector-Based Gene Therapy Market Share by Application (2020-2025)
Table 39. Global Viral Vector-Based Gene Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global Viral Vector-Based Gene Therapy Sales by Region (2020-2025) & (K MT)
Table 41. Global Viral Vector-Based Gene Therapy Sales Market Share by Region (2020-2025)
Table 42. Global Viral Vector-Based Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Viral Vector-Based Gene Therapy Market Size by Region (2020-2025)
Table 44. North America Viral Vector-Based Gene Therapy Sales by Country (2020-2025) & (K MT)
Table 45. North America Viral Vector-Based Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Viral Vector-Based Gene Therapy Sales by Country (2020-2025) & (K MT)
Table 47. Europe Viral Vector-Based Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Viral Vector-Based Gene Therapy Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Viral Vector-Based Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Viral Vector-Based Gene Therapy Sales by Country (2020-2025) & (K MT)
Table 51. South America Viral Vector-Based Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Viral Vector-Based Gene Therapy Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Viral Vector-Based Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Viral Vector-Based Gene Therapy Production (K MT) by Region(2020-2025)
Table 55. Global Viral Vector-Based Gene Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Viral Vector-Based Gene Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global Viral Vector-Based Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Viral Vector-Based Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Viral Vector-Based Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Viral Vector-Based Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Viral Vector-Based Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sibiono Basic Information
Table 63. Sibiono Viral Vector-Based Gene Therapy Product Overview
Table 64. Sibiono Viral Vector-Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sibiono Business Overview
Table 66. Sibiono SWOT Analysis
Table 67. Sibiono Recent Developments
Table 68. Rigvir Group Basic Information
Table 69. Rigvir Group Viral Vector-Based Gene Therapy Product Overview
Table 70. Rigvir Group Viral Vector-Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Rigvir Group Business Overview
Table 72. Rigvir Group SWOT Analysis
Table 73. Rigvir Group Recent Developments
Table 74. Shanghai Pharma (Sunway) Basic Information
Table 75. Shanghai Pharma (Sunway) Viral Vector-Based Gene Therapy Product Overview
Table 76. Shanghai Pharma (Sunway) Viral Vector-Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Shanghai Pharma (Sunway) Business Overview
Table 78. Shanghai Pharma (Sunway) SWOT Analysis
Table 79. Shanghai Pharma (Sunway) Recent Developments
Table 80. Amgen Basic Information
Table 81. Amgen Viral Vector-Based Gene Therapy Product Overview
Table 82. Amgen Viral Vector-Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Amgen Business Overview
Table 84. Amgen Recent Developments
Table 85. Spark Therapeutics Basic Information
Table 86. Spark Therapeutics Viral Vector-Based Gene Therapy Product Overview
Table 87. Spark Therapeutics Viral Vector-Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Spark Therapeutics Business Overview
Table 89. Spark Therapeutics Recent Developments
Table 90. Novartis Gene Therapies Basic Information
Table 91. Novartis Gene Therapies Viral Vector-Based Gene Therapy Product Overview
Table 92. Novartis Gene Therapies Viral Vector-Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Novartis Gene Therapies Business Overview
Table 94. Novartis Gene Therapies Recent Developments
Table 95. Daiichi Sankyo Basic Information
Table 96. Daiichi Sankyo Viral Vector-Based Gene Therapy Product Overview
Table 97. Daiichi Sankyo Viral Vector-Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Daiichi Sankyo Business Overview
Table 99. Daiichi Sankyo Recent Developments
Table 100. PTC Therapeutics Basic Information
Table 101. PTC Therapeutics Viral Vector-Based Gene Therapy Product Overview
Table 102. PTC Therapeutics Viral Vector-Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. PTC Therapeutics Business Overview
Table 104. PTC Therapeutics Recent Developments
Table 105. Global Viral Vector-Based Gene Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global Viral Vector-Based Gene Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America Viral Vector-Based Gene Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America Viral Vector-Based Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe Viral Vector-Based Gene Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe Viral Vector-Based Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific Viral Vector-Based Gene Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific Viral Vector-Based Gene Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Viral Vector-Based Gene Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America Viral Vector-Based Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa Viral Vector-Based Gene Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa Viral Vector-Based Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global Viral Vector-Based Gene Therapy Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global Viral Vector-Based Gene Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global Viral Vector-Based Gene Therapy Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global Viral Vector-Based Gene Therapy Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global Viral Vector-Based Gene Therapy Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Viral Vector-Based Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Viral Vector-Based Gene Therapy Market Size (M USD), 2025-2035
Figure 5. Global Viral Vector-Based Gene Therapy Market Size (M USD) (2020-2035)
Figure 6. Global Viral Vector-Based Gene Therapy Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Viral Vector-Based Gene Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Viral Vector-Based Gene Therapy Product Life Cycle
Figure 13. Viral Vector-Based Gene Therapy Sales Share by Manufacturers in 2025
Figure 14. Global Viral Vector-Based Gene Therapy Revenue Share by Manufacturers in 2025
Figure 15. Viral Vector-Based Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Viral Vector-Based Gene Therapy Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Viral Vector-Based Gene Therapy Revenue in 2025
Figure 18. Industry Chain Map of Viral Vector-Based Gene Therapy
Figure 19. Global Viral Vector-Based Gene Therapy Market PEST Analysis
Figure 20. Global Viral Vector-Based Gene Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Viral Vector-Based Gene Therapy Market Share by Type
Figure 27. Sales Market Share of Viral Vector-Based Gene Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Viral Vector-Based Gene Therapy by Type in 2025
Figure 29. Market Share of Viral Vector-Based Gene Therapy by Type (2020-2025)
Figure 30. Market Share of Viral Vector-Based Gene Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Viral Vector-Based Gene Therapy Market Share by Application
Figure 33. Global Viral Vector-Based Gene Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Viral Vector-Based Gene Therapy Sales Market Share by Application in 2025
Figure 35. Global Viral Vector-Based Gene Therapy Market Share by Application (2020-2025)
Figure 36. Global Viral Vector-Based Gene Therapy Market Share by Application in 2025
Figure 37. Global Viral Vector-Based Gene Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Viral Vector-Based Gene Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Viral Vector-Based Gene Therapy Market Size by Region (2020-2025)
Figure 40. North America Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Viral Vector-Based Gene Therapy Sales Market Share by Country in 2024
Figure 43. North America Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Viral Vector-Based Gene Therapy Market Size by Country in 2024
Figure 45. U.S. Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Viral Vector-Based Gene Therapy Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Viral Vector-Based Gene Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Viral Vector-Based Gene Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Viral Vector-Based Gene Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Viral Vector-Based Gene Therapy Sales Market Share by Country in 2024
Figure 53. Europe Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Viral Vector-Based Gene Therapy Market Size by Country in 2024
Figure 55. Germany Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Viral Vector-Based Gene Therapy Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Viral Vector-Based Gene Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Viral Vector-Based Gene Therapy Market Size by Region in 2024
Figure 68. China Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Viral Vector-Based Gene Therapy Sales and Growth Rate (K MT)
Figure 79. South America Viral Vector-Based Gene Therapy Sales Market Share by Country in 2024
Figure 80. South America Viral Vector-Based Gene Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Viral Vector-Based Gene Therapy Market Size by Country in 2024
Figure 82. Brazil Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Viral Vector-Based Gene Therapy Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Viral Vector-Based Gene Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Viral Vector-Based Gene Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Viral Vector-Based Gene Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Viral Vector-Based Gene Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Viral Vector-Based Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Viral Vector-Based Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Viral Vector-Based Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 106. China Viral Vector-Based Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Viral Vector-Based Gene Therapy Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Viral Vector-Based Gene Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Viral Vector-Based Gene Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Viral Vector-Based Gene Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global Viral Vector-Based Gene Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global Viral Vector-Based Gene Therapy Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Viral Vector-Based Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Viral Vector-Based Gene Therapy Market Size (M USD), 2025-2035
Figure 5. Global Viral Vector-Based Gene Therapy Market Size (M USD) (2020-2035)
Figure 6. Global Viral Vector-Based Gene Therapy Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Viral Vector-Based Gene Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Viral Vector-Based Gene Therapy Product Life Cycle
Figure 13. Viral Vector-Based Gene Therapy Sales Share by Manufacturers in 2025
Figure 14. Global Viral Vector-Based Gene Therapy Revenue Share by Manufacturers in 2025
Figure 15. Viral Vector-Based Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Viral Vector-Based Gene Therapy Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Viral Vector-Based Gene Therapy Revenue in 2025
Figure 18. Industry Chain Map of Viral Vector-Based Gene Therapy
Figure 19. Global Viral Vector-Based Gene Therapy Market PEST Analysis
Figure 20. Global Viral Vector-Based Gene Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Viral Vector-Based Gene Therapy Market Share by Type
Figure 27. Sales Market Share of Viral Vector-Based Gene Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Viral Vector-Based Gene Therapy by Type in 2025
Figure 29. Market Share of Viral Vector-Based Gene Therapy by Type (2020-2025)
Figure 30. Market Share of Viral Vector-Based Gene Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Viral Vector-Based Gene Therapy Market Share by Application
Figure 33. Global Viral Vector-Based Gene Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Viral Vector-Based Gene Therapy Sales Market Share by Application in 2025
Figure 35. Global Viral Vector-Based Gene Therapy Market Share by Application (2020-2025)
Figure 36. Global Viral Vector-Based Gene Therapy Market Share by Application in 2025
Figure 37. Global Viral Vector-Based Gene Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Viral Vector-Based Gene Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Viral Vector-Based Gene Therapy Market Size by Region (2020-2025)
Figure 40. North America Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Viral Vector-Based Gene Therapy Sales Market Share by Country in 2024
Figure 43. North America Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Viral Vector-Based Gene Therapy Market Size by Country in 2024
Figure 45. U.S. Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Viral Vector-Based Gene Therapy Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Viral Vector-Based Gene Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Viral Vector-Based Gene Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Viral Vector-Based Gene Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Viral Vector-Based Gene Therapy Sales Market Share by Country in 2024
Figure 53. Europe Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Viral Vector-Based Gene Therapy Market Size by Country in 2024
Figure 55. Germany Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Viral Vector-Based Gene Therapy Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Viral Vector-Based Gene Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Viral Vector-Based Gene Therapy Market Size by Region in 2024
Figure 68. China Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Viral Vector-Based Gene Therapy Sales and Growth Rate (K MT)
Figure 79. South America Viral Vector-Based Gene Therapy Sales Market Share by Country in 2024
Figure 80. South America Viral Vector-Based Gene Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Viral Vector-Based Gene Therapy Market Size by Country in 2024
Figure 82. Brazil Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Viral Vector-Based Gene Therapy Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Viral Vector-Based Gene Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Viral Vector-Based Gene Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Viral Vector-Based Gene Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Viral Vector-Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Viral Vector-Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Viral Vector-Based Gene Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Viral Vector-Based Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Viral Vector-Based Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Viral Vector-Based Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 106. China Viral Vector-Based Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Viral Vector-Based Gene Therapy Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Viral Vector-Based Gene Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Viral Vector-Based Gene Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Viral Vector-Based Gene Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global Viral Vector-Based Gene Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global Viral Vector-Based Gene Therapy Market Share Forecast by Application (2026-2035)
